# Dalfampridine

NDC: 82249-702
Generic name: Dalfampridine
Labeler / Manufacturer: CivicaScript LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20250721

FDA application: ANDA206765

## Active ingredients

- DALFAMPRIDINE: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"82249-702"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=82249-702
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c40dcc84-b839-44aa-94f2-886fb1c3d75c